SCHEMBL6795437

SCHEMBL6795437

CCCCCc1ccc(C(=O)N(CCN(CCCC)CCCC)Cc2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7210516 0.96 BCHE (0.60)
SCHEMBL7209272 0.87
SCHEMBL1123389 0.85 BCHE (0.57)
SCHEMBL6788161 0.85
SCHEMBL7210509 0.84 BCHE (0.51)
SCHEMBL6790189 0.83
SCHEMBL7214896 0.83 BCHE (0.57)
SCHEMBL1123268 0.83 BCHE (0.56)
SCHEMBL1123374 0.82 BCHE (0.54)
SCHEMBL7215478 0.82 LPAR1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067927-A1 Substituted alkyldiamines ACTELION PHARMACEUTICALS LTD. (CH) 2004-04-08 US claimed
EP-1335899-A2 SUBSTITUTED ALKYLDIAMINES AS INHIBITORS OF PLASMEPSIN OR RELATED PROTEASES Actelion Pharmaceuticals Ltd. (CH) 2003-08-20 EP claimed
WO-2002038534-A2 SUBSTITUTED ALKYLDIAMINES AS INHIBITORS OF PLASMEPSIN OR RELATED PROTEASES ACTELION PHARMACEUTICALS LTD (CH) 2002-05-16 WO claimed
US-20040067927-A1 Substituted alkyldiamines ACTELION PHARMACEUTICALS LTD. (CH) 2004-04-08 US disclosed
EP-1335899-A2 SUBSTITUTED ALKYLDIAMINES AS INHIBITORS OF PLASMEPSIN OR RELATED PROTEASES Actelion Pharmaceuticals Ltd. (CH) 2003-08-20 EP disclosed
WO-2002038534-A2 SUBSTITUTED ALKYLDIAMINES AS INHIBITORS OF PLASMEPSIN OR RELATED PROTEASES ACTELION PHARMACEUTICALS LTD (CH) 2002-05-16 WO disclosed